KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Invested Capital (2016 - 2025)

Historic Invested Capital for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • West Pharmaceutical Services' Invested Capital rose 1712.02% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 1712.02%. This contributed to the annual value of $3.4 billion for FY2025, which is 1712.02% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Invested Capital of $3.4 billion as of Q4 2025, which was up 1712.02% from $3.3 billion recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Invested Capital ranged from a high of $3.4 billion in Q4 2025 and a low of $2.1 billion during Q1 2021
  • Its 5-year average for Invested Capital is $2.8 billion, with a median of $2.9 billion in 2024.
  • In the last 5 years, West Pharmaceutical Services' Invested Capital skyrocketed by 2439.99% in 2021 and then plummeted by 657.1% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Invested Capital (Quarter) stood at $2.6 billion in 2021, then rose by 11.8% to $2.9 billion in 2022, then increased by 6.7% to $3.1 billion in 2023, then fell by 6.57% to $2.9 billion in 2024, then increased by 17.12% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q4 2025, $3.3 billion for Q3 2025, and $3.1 billion during Q2 2025.